BBR improves glucose and lipid metabolism in obese mice through the reduction of IRE1/GSK-3β axis-mediated inflammation, showing the great potential of BBR in reversing insulin resistance in obesity. Here, ERN1 is linked to obesity due to melanocortin 4 receptor deficiency.